CTHIn ForceLegislation
National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No.1)
Part 3Combined bacterial and viral vaccines
Start here
Get a plain-English read of Part 3
Turn the raw legal text into a practical explanation grounded in National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No.1).
Part 3 Combined bacterial and viral vaccines
| Item | Vaccine and the circumstances in which vaccine may be provided | Brand | Formulation | Active ingredient and strength | Number and timing of doses |
|---|---|---|---|---|---|
| 301 | VaccineDiphtheria, tetanus, pertussis and poliomyelitisCircumstancesVaccine may be provided to a child who is about 2, 4 or 6 months old, or between 3 years and 6 months and 4 years of age. | Infanrix‑IPV | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 30 IU;(b) tetanus toxoid — not less than 40 IU;(c) PT — 25 µg;(d) FHA — 25 µg;(e) PRN — 8 µg;(f) inactivated poliovirus type 1 (Mahoney) — 40 D‑antigen units;(g) inactivated poliovirus type 2 (MEF‑1) — 8 D‑antigen units;(h) inactivated poliovirus type 3 (Saukett) —32 D‑antigen units | 4 doses |
| 302 | VaccineDiphtheria, tetanus, pertussis and poliomyelitisCircumstancesVaccine may be provided to a child who is about 2, 4 or 6 months old, or between 3 years and 6 months and 4 years of age. | Quadracel | Vial for injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 30 IU;(b) tetanus toxoid — not less than 40 IU;(c) PT — 20 µg;(d) FHA — 20 µg;(e) PRN — 3 µg;(f) FIM 2+3 — 5 µg;(g) inactivated poliovirus type 1 (Mahoney) — 40 D‑antigen units;(h) inactivated poliovirus type 2 (MEF‑1) — 8 D‑antigen units;(i) inactivated poliovirus type 3 (Saukett) — 32 D‑antigen units | 4 doses |
| 303 | VaccineDiphtheria, tetanus, pertussis, poliomyelitis and hepatitis BCircumstancesVaccine may be provided to a child who is about 2, 4 or 6 months old. | Infanrix‑Penta | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 30 IU;(b) tetanus toxoid — not less than 40 IU;(c) PT — 25 µg;(d) FHA — 25 µg;(e) PRN — 8 µg;(f) inactivated poliovirus type 1 (Mahoney) — 40 D‑antigen units;(g) inactivated poliovirus type 2 (MEF‑1) — 8 D‑antigen units;(h) inactivated poliovirus type 3 (Saukett) — 32 D‑antigen units;(i) recombinant hepatitis B surface antigen — 10 µg | 3 doses |
| 304 | VaccineDiphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib)CircumstancesVaccine may be provided to a child who is about 2, 4 or 6 months old. | Pediacel | Injection (0.5mL) | Each of the following:(a) diphtheria toxoid — not less than 30 IU;(b) tetanus toxoid — not less than 40 IU;(c) PT — 20 µg;(d) FHA — 20 µg;(e) PRN — 3 µg;(f) FIM 2+3 — 5 µg;(g) inactivated poliovirus type 1 (Mahoney) — 40 D‑antigen units;(h) inactivated poliovirus type 2 (MEF‑1) — 8 D‑antigen units;(i) inactivated poliovirus type 3 (Saukett) — 32 D‑antigen units;(j) purified Hib capsular polysaccharide conjugated to tetanus toxoid — 10 µg |